derinet® Switzerland
Product names from:
VontobelSVSP
Back

5.80% (5.14% p.a.) Barrier Reverse Convertible on Pfizer Inc.

  • Valor 50609864
  • ISIN CH0506098646
  • Symbol RPFABV
Bid (indicative)%
Ask (indicative)%
CurrencyUSD
Price on
Sell
Buy
Pfizer Inc.USD 
Please note that this is an indication.

Documents

Key data
Yield max.7.86%
Yield max. p.a.9.56%
Barrier reachedno
Riskbuffer21.35%
Interest
Coupon (Coupon p.a.)5.80% (5.14%)
Accrued interest1.57%
Premium component3.6146%
Interest share2.1854%
Day count convention30/360
Pricingclean
Life cycle
Initial fixing29/10/2019
Payment date05/11/2019
Last trading day14/12/2020
Final fixing14/12/2020
Redemption21/12/2020

Current price information

Intraday1 week1 monthyear to dateSince emission
until
Product Underlying

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrierBuffer
USD 34.67USD 38.39USD 26.8721.35%

No chart available

Key data
Yield max.7.86%
Yield max. p.a.9.56%
Barrier reachedno
Riskbuffer21.35%
Interest
Coupon (Coupon p.a.)5.80% (5.14%)
Accrued interest1.57%
Premium component3.6146%
Interest share2.1854%
Day count convention30/360
Pricingclean
Life cycle
Initial fixing29/10/2019
Payment date05/11/2019
Last trading day14/12/2020
Final fixing14/12/2020
Redemption21/12/2020
Figures
Product typeDefender VONTI
SSPA categorisationBarriere Reverse Convertible
Issue price100.00%
Nominal valueUSD 1,000.00
Reference currencyUSD
QuantoNo
Strike price

Reference price of the underlying used to calculate the cash settlement on expiry of the warrant. In cases of physical delivery it is the price at which the underlying is bought (call) or sold (put). Also called: exercise price

USD 38.39
BarrierUSD 26.87 (70.00%)
Barrier observationcontinuous
Underlying/
ISIN of underlying
Pfizer
US7170811035
Spot reference priceUSD 38.39
COSINo
ListingSIX Structured Products Exchange
Additional conditions
IssuerVontobel Financial Products Ltd., DIFC Dubai
GuarantorVontobel Holding AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliveryphysical delivery
Issuance ProgrammeLink to the Issuance Program